NF-κB in the mechanism of brain edema in acute liver failure: Studies in transgenic mice

Neurobiology of Disease

Volumn 41, Issue 2, 2011, Pages 498-507

  Jayakumar, A R ^a,b   Bethea, J R ^a   Tong, X Y ^a   Gomez, J ^b   Norenberg, M D ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute liver failure; Ammonia; Astrocyte swelling; INOS; NADPH oxidase; NF B

Indexed keywords

AMMONIA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN AMMONIA LEVEL; BRAIN CORTEX; BRAIN EDEMA; BRAIN LEVEL; CELL CULTURE; CELL SWELLING; CONTROLLED STUDY; CYTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER FAILURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACUTE DISEASE; ANIMALS; ASTROCYTES; BRAIN EDEMA; DISEASE MODELS, ANIMAL; HEPATIC ENCEPHALOPATHY; MICE; MICE, TRANSGENIC; NF-KAPPA B;

EID: 78650604333     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.10.021     Document Type: Article

References (66)

1. Albrecht J., Jones E.A. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 1999, 170:38-146.
2. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
3. Beckman J.S. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 1991, 15:53-59.
4. Bémeur C., et al. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem. Int. 2010, 56:213-215.
5. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 2000, 59:13-23.
6. Bracchi-Ricard V., et al. Astroglial nuclear factor-kappaB regulates learning and memory and synaptic plasticity in female mice. J. Neurochem. 2008, 104:611-623.
7. Brambilla R., et al. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
8. Brambilla R., et al. Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J. Neurochem. 2009, 110:765-778.
9. Brambilla R., et al. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 2009, 182:2628-2640.
10. Detry O., et al. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World. J. Gastroenterol. 2006, 12:7405-7412.
11. Ducis I., et al. The benzodiazepine receptor in cultured astrocytes from genetically epilepsy prone rats. Brain. Res. 1990, 531:318-321.
12. Dvoriantchikova G., et al. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur. J. Neurosci. 2009, 30:175-185.
13. Fu E.S., et al. Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice. Neuroreport 2007, 18:713-717.
14. Fu E.S., et al. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain 2010, 148:509-518.
15. Gammal S., et al. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 1990, 11:371-378.
16. Gregorios J.B., et al. Morphologic effects of ammonia on primary astrocyte cultures: I. Light microscopic studies. J. Neuropathol. Exp. Neurol. 1985, 44:397-403.
17. Hazell A.S., Butterworth R.F. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med. 1999, 222:99-112.
18. Hilgier W., Olson J.E. Brain ion and amino acid contents during edema development in hepatic encephalopathy. J. Neurochem. 1994, 62:197-204.
19. Itzhak Y., et al. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain. Res. 1995, 705:345-348.
20. Jaimes E.A., et al. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1031-1036.
21. Jalan R., Williams R. The inflammatory basis of intracranial hypertension in acute liver failure. J. Hepatol. 2001, 34:940-942.
22. Jayakumar A.R., et al. Oxidative stress and mitogen-activated protein kinase phos-phorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci. 2006, 26:4774-4784.
23. Jayakumar A.R., et al. Na-K-Cl cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J. Biol. Chem. 2008, 283:33874-33882.
24. Jayakumar A.R., et al. Calcium in the mechanism of ammonia-induced astrocyte swelling. J. Neurochem. 2009, 109(Suppl 1):252-257.
25. Jiang W., et al. Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. J. Cereb. Blood. Flow. Metab. 2009, 29:944-952.
26. Juurlink B.H., Hertz L. Plasticity of astrocytes in primary cultures: an experimental tool and a reason for methodological caution. Dev. Neurosci. 1985, 7:263-277.
27. Kimelberg H.K. Anisotonic media and glutamate-induced ion transport and volume responses in primary astrocyte cultures. J. Physiol (Paris) 1987, 82:294-303.
28. Kimura T., Budka H. Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Acta. Neuropathol. 1986, 70:17-21.
29. Kleinert H., et al. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 2004, 500:255-266.
30. Kletzien R.F., et al. A method using 3-O-methyl-D-glucose and phloretin for the determination of intracellular water space of cells in monolayer culture. Ann. Biochem. 1975, 68:537-544.
31. Kretzschmar H.A., et al. Measurement of GFAP in hepatic encephalopathy by ELISA and transblots. J. Neuropathol. Exp. Neurol. 1985, 44:459-471.
32. Linares G., Mayer S.A. Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit. Care. Med. 2009, 37:S243-S249.
33. Luengo-Blanco M., et al. Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes. Blood 2008, 112:1453-1460.
34. Manea A., et al. Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells. Arch. Physiol. Biochem. 2007, 113:163-172.
35. Mans A.M., et al. Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J. Neurochem. 1979, 32:285-292.
36. Marmarou A., et al. A simple gravimetric technique for measurement of cerebral edema. J. Neurosurg. 1978, 49:530-537.
37. Norenberg M.D. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab. Invest. 1977, 36:618-627.
38. Norenberg M.D. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin. Liver. Dis. 1996, 16:245-253.
39. Norenberg M.D., et al. Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes. J. Neuropathol. Exp. Neurol. 1990, 49:399-405.
40. Norenberg M.D., et al. Ammonia-induced astrocyte swelling in primary culture. Neurochem. Res. 1991, 16:833-836.
41. Norenberg M.D., et al. Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2004, 19:313-329.
42. Norenberg M.D., et al. New concepts in the mechanism of ammonia-induced astrocyte swelling. Metab. Brain. Dis. 2007, 22:219-234.
43. Norenberg M.D., et al. Signaling factors in the mechanism of ammonia neurotoxicity. Metab. Brain. Dis. 2009, 24:103-117.
44. O'Beirne J.P., et al. The role of infection and inflammation in the pathogenesis of hepatic encephalopathy and cerebral edema in acute liver failure. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:118-119.
45. O'Grady J.G., Williams R. Management of acute liver failure. Schweiz. Med. Wochenschr. 1986, 116:541-544.
46. Rama Rao K.V., et al. Brain edema in acute liver failure: inhibition by L-histidine. Am. J. Pathol. 2010, 176:1400-1408.
47. Reinehr R., et al. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia 2007, 55:758-771.
48. Rosomoff H.L., et al. Resuscitation from severe brain trauma. Crit. Care. Med. 1996, 24:S48-S56.
49. Sarhan S., et al. Effect of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy. Neurochem. Res. 1993, 18:539-549.
50. Schliess F., et al. Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J. 2002, 16:739-741.
51. Shawcross D., et al. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell. Mol. Life. Sci. 2005, 62:2295-2304.
52. Sinke A.P., et al. NF-kappaB in the mechanism of ammonia-induced astrocyte swelling in culture. J. Neurochem. 2008, 106:2302-2311.
53. Sobel R.A., et al. Glial fibrillary acidic protein in hepatic encephalopathy. An immunohistochemical study. J. Neuropathol. Exp. Neurol. 1981, 40:625-632.
54. Stancovski I., Baltimore D. NF-kappaB activation: the I kappaB kinase revealed?. Cell 1997, 91:299-302.
55. Stanislaus R., et al. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci. Lett. 1999, 269:71-74.
56. Swain M.S., et al. Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats. Am. J. Physiol. 1991, 261:R1491-R1496.
57. Swain M., et al. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 1992, 15:449-453.
58. Traber P.G., et al. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 1987, 7:1272-1277.
59. Verma I.M., Stevenson J. IkappaB kinase: beginning, not the end. Proc. Natl. Acad. Sci. U S A. 1997, 94:11758-11760.
60. Voorhies T.M., et al. Acute hyperammonemia in the young primate: physiologic and neuropathologic correlates. Pediatr. Res. 1983, 17:970-975.
61. Willard-Mack C.L., et al. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 1996, 71:589-599.
62. Wright G., et al. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab. Brain. Dis. 2007, 22:375-388.
63. Xie Q.W., et al. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
64. Zielinska M., et al. Excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia. Neurochem. Int. 2003, 43:299-303.
65. Zimmermann Z., et al. Hepatic encephalopathy in thioacetamide induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 1989, 9:54-60.
66. Zwingmann C., et al. Effects of ammonia exposition on glioma cells: changes in cell volume and organic osmolytes studied by diffusion-weighted and high-resolution NMR spectroscopy. Dev. Neurosci. 2000, 22:463-471.